Amynah Pradhan, PhD

Washington University in St. Louis

Dr. Pradhan is the Director for the Center of Clinical Pharmacology at Washington University and the University of Health Sciences and Pharmacy in St. Louis. Her lab investigates novel therapies for migraine, and she identified the delta opioid receptor as a promising target for this disorder. Ongoing studies in her lab are focused on the differential role of mu and delta opioid receptors in headache. Additionally, the lab focuses on identifying the molecular mechanisms that contribute to migraine chronicity, as well as overlapping mechanisms between migraine and neuropsychiatric conditions.


NOTE: If no session is listed above, this individual is a Chair or Co-chair of a session(s). Please see the individual session listings found in the Program for a full list of session participants.